Evidence map›Paper›PMID 25347859›Full record

ArticlePhysiological reports2014

Hypomethylation of the promoter of the catalytic subunit of protein phosphatase 2A in response to hyperglycemia.

Fabiola Tros, Aline Meirhaeghe, Samy Hadjadj, Philippe Amouyel, Pierre Bougnères, Delphine Fradin

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Fabiola TrosINSERM U986, Bicêtre Hospital, Paris Sud University, Le Kremlin-Bicêtre, France UMR1002, Paris, France.
Aline MeirhaegheINSERM, U744, Lille, France Institut Pasteur de Lille, Université Lille Nord de France, Lille, France UDSL, Lille, France.
Samy HadjadjDepartment of Diabetology, Poitiers Hospital, INSERM U927, INSERM CIC 802, Université de Poitiers, UFR Médecine Pharmacie, Poitiers, France.
Philippe AmouyelINSERM, U744, Lille, France Institut Pasteur de Lille, Université Lille Nord de France, Lille, France UDSL, Lille, France.
Pierre BougnèresINSERM U986, Bicêtre Hospital, Paris Sud University, Le Kremlin-Bicêtre, France Department of Pediatric Endocrinology, Bicêtre Hospital, Paris Sud University, Le Kremlin-Bicêtre, France.
Delphine FradinINSERM U986, Bicêtre Hospital, Paris Sud University, Le Kremlin-Bicêtre, France.
Inserm · FRBicêtre Hospital · FRInstitut Pasteur de Lille · FRUniversité de Poitiers · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to identify epigenetic mechanisms through which hyperglycemia can affect gene expression durably in β cells, we screened DNA methylation changes induced by high glucose concentrations (25 mmol/L) in the BTC3 murine cell line, using an epigenome-wide approach. Exposure of BTC3 cells to high glucose modified the expression of 1612 transcripts while inducing significant methylation changes in 173 regions. Among these 173 glucose-sensitive differentially methylated regions (DMRs), 14 were associated with changes in gene expression, suggesting an epigenetic effect of high glucose on gene transcription at these loci. Among these 14 DMRs, we selected for further study Pp2ac, a gene previously suspected to play a role in β-cell physiology and type 2 diabetes. Using RT-qPCR and bisulfite pyrosequencing, we confirmed our previous observations in BTC3 cells and found that this gene was significantly demethylated in the whole blood cells (WBCs) of type 2 diabetic patients compared to controls.

Indexed as

DNA methylationgene expressionhyperglycemiatype 2 diabetesβ cells

Identifiers

PMID25347859
PMCPMC4187575
OpenAlexW2113483234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.